Related Experiment Video
Updated: Jul 29, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Microbial treatment: the potential application for Parkinson's disease
1Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China. fangx2011@163.com.
Summary
Microbial therapies, including probiotics and fecal microbiota transplantation (FMT), show promise for treating Parkinson's disease (PD). These gut health interventions may help manage PD symptoms and combat neurotoxicity.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Gut microbiota alterations are linked to Parkinson's disease (PD) pathophysiology.
- Animal models suggest a causal relationship between gut flora and PD pathogenesis.
- Constipation, a common PD symptom, may be alleviated by probiotics.
Purpose of the Study:
- To review the potential of microbial therapies for Parkinson's disease treatment.
- To discuss the role of probiotics and fecal microbiota transplantation (FMT) in PD management.
Main Methods:
- Review of recent studies on gut microbiota and Parkinson's disease.
- Analysis of findings from PD animal models regarding neurotoxicity.
- Evaluation of clinical evidence for probiotic and FMT efficacy in PD patients.
Main Results:
- Probiotics have demonstrated efficacy in improving constipation in PD patients.
- Fecal microbiota transplantation (FMT) showed a protective effect against MPTP-induced neurotoxicity in mice.
- Microbial therapies, including probiotics and FMT, are emerging as effective treatments for PD.
Conclusions:
- Microbial therapy represents a novel and potentially effective approach for treating Parkinson's disease.
- Further research into probiotics and FMT could lead to new therapeutic strategies for PD.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Microbial Wastewater Treatment
Microbial communities in aquatic ecosystems play a key role in the natural breakdown of contaminants introduced through domestic and industrial effluents. Acting as biological catalysts, these microbes change and mineralize a wide range of organic and inorganic pollutants under different redox conditions.In oxygen-rich surface waters, aerobic heterotrophs lead organic matter breakdown, using oxygen as the terminal electron acceptor to efficiently oxidize substrates to carbon dioxide and water.
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...